Get a deeper insight into the potential performance of PTC Therapeutics (PTCT) for the quarter ended June 2024 by going beyond Wall Street's top...

Adenoid Cystic Carcinoma Market According to DelveInsight, the dynamics of the Adenoid Cystic Carcinoma market are expected to evolve in the coming...

PTC Therapeutics (PTCT) delivered earnings and revenue surprises of -16% and 2.82%, respectively, for the quarter ended June 2024. Do the numbers hold...

Positive Phase 2a Fibromyalgia Results Deliver Pain Reduction in 100% of Patients, Strengthening IP Position and Clinical Trial Strategy Tryptamine...

Ionis (IONS) enjoys a diverse revenue stream, including numerous sources of collaborative and R&D revenues. These funds enable it to invest in the...

Competitive: Worldwide Clinical Trials - USA: Senior Project Manager, Clinical Project Management Therapeutic Experience Required: Oncology...

Beam Therapeutics (BEAM) reports mixed second-quarter results. The company remains focused on pipeline development.

Competitive: Stanford University (US): Cancer Clinical Research Coordinator Associate - Radiation Oncology (Hybrid) The Stanford Cancer Institute...

PTC Therapeutics and Almac are getting a new brain-infused gene therapy to children suffering a rare inherited condition